• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质母细胞瘤细胞中 PD-L1 表达与细胞周期蛋白 D 同步波动。

PD-L1 Expression Fluctuates Concurrently with Cyclin D in Glioblastoma Cells.

机构信息

Department of Molecular Medicine and Medical Biothecnology, University Federico II, 80131 Napoli, Italy.

Laboratory of Virology and Immunology, GIGA-R, B34, University of Liege, B-4000 Liege, Belgium.

出版信息

Cells. 2021 Sep 9;10(9):2366. doi: 10.3390/cells10092366.

DOI:10.3390/cells10092366
PMID:34572014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8468141/
Abstract

Despite Glioblastoma (GBM) frequently expressing programmed cell death ligand-1 (PD-L1), treatment with anti-programmed cell death-1 (PD1) has not yielded brilliant results. Intratumor variability of PD-L1 can impact determination accuracy. A previous study on mouse embryonic fibroblasts (MEFs) reported a role for cyclin-D in control of PD-L1 expression. Because tumor-cell growth within a cancer is highly heterogeneous, we looked at whether PD-L1 and its cochaperone FKBP51s were influenced by cell proliferation, using U251 and SF767 GBM-cell-lines. PD-L1 was measured by Western blot, flow cytometry, confocal-microscopy, quantitative PCR (qPCR), by qPCR, FKBP51s by Western blot and confocal-microscopy. Chromatin-Immunoprecipitation assay (xChIp) served to assess the DNA-binding of FKBP51 isoforms. In the course of cell culture, PD-L1 appeared to increase concomitantly to cyclin-D on G1/S transition, to decrease during exponential cell growth progressively. We calculated a correlation between and gene expression levels. In the temporal window of and peak, FKBP51s localized in ER. When cyclin-D declined, FKBP51s went nuclear. XChIp showed that FKBP51s binds gene in a closed-chromatin configuration. Our finding suggests that the dynamism of PD-L1 expression in GBM follows cyclin-D fluctuation and raises the hypothesis that FKBP51s might participate in the events that govern cyclin-D oscillation.

摘要

尽管胶质母细胞瘤(GBM)经常表达程序性细胞死亡配体-1(PD-L1),但抗程序性细胞死亡-1(PD1)的治疗并未产生显著效果。PD-L1 在肿瘤内的变异性可能会影响测定的准确性。先前在小鼠胚胎成纤维细胞(MEFs)上的研究报告了细胞周期蛋白-D 在控制 PD-L1 表达中的作用。由于癌症内的肿瘤细胞生长高度异质,我们研究了 PD-L1 及其共伴侣 FKBP51s 是否受到细胞增殖的影响,使用 U251 和 SF767 GBM 细胞系。通过 Western blot、流式细胞术、共聚焦显微镜、定量 PCR(qPCR)测量 PD-L1,通过 Western blot 和共聚焦显微镜测量 FKBP51s。染色质免疫沉淀测定(xChIp)用于评估 FKBP51 同工型的 DNA 结合。在细胞培养过程中,PD-L1 似乎在 G1/S 转换时与细胞周期蛋白-D 同时增加,在指数细胞生长过程中逐渐减少。我们计算了 基因表达水平之间的相关性。在 基因表达的时间窗口中,FKBP51s 定位于 ER 中。当细胞周期蛋白-D 下降时,FKBP51s 进入细胞核。xChIp 显示 FKBP51s 以封闭染色质构象结合 基因。我们的发现表明,GBM 中 PD-L1 表达的动态变化遵循细胞周期蛋白-D 的波动,并提出 FKBP51s 可能参与调控细胞周期蛋白-D 振荡的假说。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3d/8468141/c2c0a2f8d02b/cells-10-02366-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3d/8468141/4443a306e34b/cells-10-02366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3d/8468141/6da83ac64041/cells-10-02366-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3d/8468141/870f7a1c26c3/cells-10-02366-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3d/8468141/c2c0a2f8d02b/cells-10-02366-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3d/8468141/4443a306e34b/cells-10-02366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3d/8468141/6da83ac64041/cells-10-02366-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3d/8468141/870f7a1c26c3/cells-10-02366-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3d/8468141/c2c0a2f8d02b/cells-10-02366-g004.jpg

相似文献

1
PD-L1 Expression Fluctuates Concurrently with Cyclin D in Glioblastoma Cells.胶质母细胞瘤细胞中 PD-L1 表达与细胞周期蛋白 D 同步波动。
Cells. 2021 Sep 9;10(9):2366. doi: 10.3390/cells10092366.
2
A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma.共伴侣蛋白FKBP51在胶质瘤中PD-L1表达中的调节作用。
Oncotarget. 2017 Jul 17;8(40):68291-68304. doi: 10.18632/oncotarget.19309. eCollection 2017 Sep 15.
3
EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma.EGFR-ERK 通路调节 CSN6 促进胶质母细胞瘤中 PD-L1 的表达。
Mol Carcinog. 2020 May;59(5):520-532. doi: 10.1002/mc.23176. Epub 2020 Mar 5.
4
The FKBP51s Splice Isoform Predicts Unfavorable Prognosis in Patients with Glioblastoma.FKBP51s 剪接异构体预测胶质母细胞瘤患者预后不良。
Cancer Res Commun. 2024 May 16;4(5):1296-1306. doi: 10.1158/2767-9764.CRC-24-0083.
5
MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas.MET 过表达导致与原发性脑胶质瘤中肿瘤相关的巨噬细胞介导的免疫抑制相关的 STAT4-PD-L1 信号激活。
J Immunother Cancer. 2021 Oct;9(10). doi: 10.1136/jitc-2021-002451.
6
Combining Magnetic Resonance Imaging with Systemic Monocyte Evaluation for the Implementation of GBM Management.将磁共振成像与全身单核细胞评估相结合,实施 GBM 管理。
Int J Mol Sci. 2021 Apr 6;22(7):3797. doi: 10.3390/ijms22073797.
7
Alternative macrophage polarisation associated with resistance to anti-PD1 blockade is possibly supported by the splicing of FKBP51 immunophilin in melanoma patients.在黑色素瘤患者中,FKBP51 免疫抑制因子的剪接可能支持与抗 PD-1 阻断耐药相关的替代性巨噬细胞极化。
Br J Cancer. 2020 Jun;122(12):1782-1790. doi: 10.1038/s41416-020-0840-8. Epub 2020 Apr 22.
8
Prognostic relevance of programmed cell death ligand 1 expression in glioblastoma.程序性细胞死亡配体 1 表达在胶质母细胞瘤中的预后相关性。
J Neurooncol. 2018 Feb;136(3):453-461. doi: 10.1007/s11060-017-2675-6. Epub 2017 Nov 16.
9
Current advances in PD-1/PD-L1 axis-related tumour-infiltrating immune cells and therapeutic regimens in glioblastoma.目前在胶质母细胞瘤中与 PD-1/PD-L1 轴相关的肿瘤浸润免疫细胞和治疗方案的进展。
Crit Rev Oncol Hematol. 2020 Jul;151:102965. doi: 10.1016/j.critrevonc.2020.102965. Epub 2020 Apr 24.
10
ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma.ACT001通过抑制胶质母细胞瘤中STAT3的磷酸化来降低PD-L1的表达。
Theranostics. 2020 May 1;10(13):5943-5956. doi: 10.7150/thno.41498. eCollection 2020.

引用本文的文献

1
ZNF224 enhances the oncogenic function of p21 via p53 and AKT pathways in melanoma.锌指蛋白224通过p53和AKT信号通路增强p21在黑色素瘤中的致癌功能。
FEBS J. 2025 Aug;292(15):3986-4005. doi: 10.1111/febs.70114. Epub 2025 May 5.
2
Scaffold proteins of cancer signaling networks: The paradigm of FK506 binding protein 51 (FKBP51) supporting tumor intrinsic properties and immune escape.肿瘤信号转导网络的支架蛋白:FK506 结合蛋白 51(FKBP51)支持肿瘤内在特性和免疫逃避的范例。
Oncol Res. 2023 Jun 27;31(4):423-436. doi: 10.32604/or.2023.028392. eCollection 2023.
3
Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience.

本文引用的文献

1
Cyclin D1 in Cancer: A Molecular Connection for Cell Cycle Control, Adhesion and Invasion in Tumor and Stroma.细胞周期蛋白 D1 在癌症中的作用:肿瘤和基质中细胞周期控制、黏附和侵袭的分子联系。
Cells. 2020 Dec 9;9(12):2648. doi: 10.3390/cells9122648.
2
Modeling How Heterogeneity in Cell Cycle Length Affects Cancer Cell Growth Dynamics in Response to Treatment.模拟细胞周期长度的异质性如何影响癌细胞对治疗的生长动力学。
Front Oncol. 2020 Sep 10;10:1552. doi: 10.3389/fonc.2020.01552. eCollection 2020.
3
Spatial and Temporal Heterogeneity of PD-L1 Expression and Tumor Mutational Burden in Gastroesophageal Adenocarcinoma at Baseline Diagnosis and after Chemotherapy.
针对异柠檬酸脱氢酶1(IDH1)野生型胶质母细胞瘤成人患者的个体化多模式免疫疗法:单机构经验
Cancers (Basel). 2023 Feb 13;15(4):1194. doi: 10.3390/cancers15041194.
4
FKBP51 plays an essential role in Akt ubiquitination that requires Hsp90 and PHLPP.FKBP51 在 Akt 泛素化中发挥重要作用,该过程需要 HSP90 和 PHLPP。
Cell Death Dis. 2023 Feb 13;14(2):116. doi: 10.1038/s41419-023-05629-y.
5
The Scaffold Immunophilin FKBP51 Is a Phosphoprotein That Undergoes Dynamic Mitochondrial-Nuclear Shuttling.支架免疫亲和素 FKBP51 是一种磷酸化蛋白,可进行动态的线粒体-核穿梭。
Cells. 2022 Nov 25;11(23):3771. doi: 10.3390/cells11233771.
6
CD155 Cooperates with PD-1/PD-L1 to Promote Proliferation of Esophageal Squamous Cancer Cells via PI3K/Akt and MAPK Signaling Pathways.CD155与PD-1/PD-L1协同作用,通过PI3K/Akt和MAPK信号通路促进食管鳞状癌细胞增殖。
Cancers (Basel). 2022 Nov 15;14(22):5610. doi: 10.3390/cancers14225610.
7
FKBP51, AmotL2 and IQGAP1 Involvement in Cilastatin Prevention of Cisplatin-Induced Tubular Nephrotoxicity in Rats.FKBP51、AmotL2 和 IQGAP1 参与西司他汀预防顺铂诱导的大鼠肾小管毒性。
Cells. 2022 May 9;11(9):1585. doi: 10.3390/cells11091585.
8
Differential Expression of PD-L1 during Cell Cycle Progression of Head and Neck Squamous Cell Carcinoma.头颈鳞状细胞癌细胞周期进程中 PD-L1 的差异表达。
Int J Mol Sci. 2021 Dec 3;22(23):13087. doi: 10.3390/ijms222313087.
胃食管腺癌初诊时和化疗后 PD-L1 表达和肿瘤突变负荷的空间和时间异质性。
Clin Cancer Res. 2020 Dec 15;26(24):6453-6463. doi: 10.1158/1078-0432.CCR-20-2085. Epub 2020 Aug 20.
4
Spatial heterogeneity of PD-L1 expression and the risk for misclassification of PD-L1 immunohistochemistry in non-small cell lung cancer.非小细胞肺癌中PD-L1表达的空间异质性及PD-L1免疫组化误判风险
Lung Cancer. 2020 Sep;147:91-98. doi: 10.1016/j.lungcan.2020.07.012. Epub 2020 Jul 13.
5
PD-L1 Expression in Glioblastoma, the Clinical and Prognostic Significance: A Systematic Literature Review and Meta-Analysis.胶质母细胞瘤中PD-L1的表达、临床及预后意义:一项系统文献综述与荟萃分析
Front Oncol. 2020 Jun 24;10:1015. doi: 10.3389/fonc.2020.01015. eCollection 2020.
6
GATA2 Regulates Constitutive PD-L1 and PD-L2 Expression in Brain Tumors.GATA2 调控脑肿瘤中 PD-L1 和 PD-L2 的组成性表达。
Sci Rep. 2020 Jun 3;10(1):9027. doi: 10.1038/s41598-020-65915-z.
7
Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes.Bmi1 抑制剂 PTC-209 促进化学诱导的心脏成纤维细胞向心肌细胞的直接重编程。
Sci Rep. 2020 Apr 28;10(1):7129. doi: 10.1038/s41598-020-63992-8.
8
Cell stemness, epithelial-to-mesenchymal transition, and immunoevasion: Intertwined aspects in cancer metastasis.细胞干性、上皮间质转化和免疫逃逸:癌症转移中的交织方面。
Semin Cancer Biol. 2020 Feb;60:181-190. doi: 10.1016/j.semcancer.2019.08.015. Epub 2019 Aug 15.
9
Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response.非小细胞肺癌中 PD-L1 表达的异质性:对预测治疗反应的标本采样的影响。
Lung Cancer. 2019 Aug;134:79-84. doi: 10.1016/j.lungcan.2019.06.005. Epub 2019 Jun 5.
10
Author Correction: Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.作者更正:细胞周期蛋白D - 细胞周期蛋白依赖性激酶4通过cullin 3 - SPOP使程序性死亡蛋白1配体(PD - L1)不稳定以控制癌症免疫监视。
Nature. 2019 Jul;571(7766):E10. doi: 10.1038/s41586-019-1351-8.